Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Anesiva Announces FDA Acceptance for Filing of Zingo(TM) New Drug Application to Reduce Pain Associated With Needle Insertion Procedures in Children
Feb 7, 2007
|
12.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 07, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today that the FDA has accepted for filing the company's electronic New Drug Application (NDA)/Common Technical Document (eCTD) for marketing clearance of Zingo(TM) to treat pain associated with intravenous cannulation ...
|
|
|
Anesiva to Present at BIO CEO and Investor Conference
Feb 6, 2007
|
10.0 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 06, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that John P. McLaughlin, the company's chief executive officer, will present at the Biotechnology Industry Organization (BIO) CEO & Investor Conference 2007 in New York on February 13, 2007 at 3:00 p.m. Eastern Ti...
|
|
|
Anesiva Announces Clinical Data From Phase 1 Trial of 1207
Jan 18, 2007
|
11.1 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jan 18, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) announced today clinical data from a Phase 1 safety study of product candidate 1207, which was being tested as a topical anesthetic for treatment of neuropathic patients. 1207 achieved the primary endpoint of the study of safety ...
|
|
|
Anesiva Announces Clinical Plan for Pivotal Testing of 4975, Long-Acting Pain Candidate
Jan 8, 2007
|
14.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jan 08, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) today outlined the planned Phase 2/3 clinical trial program for the development of 4975, the company's long-acting, non-opioid drug candidate for the acute treatment of severe pain. After a successful meeting with the FDA, the co...
|
|
|
Anesiva to Host Webcast Conference Call on Monday, January 8, 2007 to Review Clinical Plan for Product Candidate, 4975
Jan 5, 2007
|
10.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jan 05, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Anesiva, Inc. (Nasdaq: ANSV) will host a webcast conference call on Monday, January 8, 2007 at 9:00 a.m. Eastern Time. Anesiva recently completed a successful meeting with the FDA regarding its clinical plan for 4975, the company's novel, long-acting, non-op...
|
|
|
Click here to download our most recent fact sheet.